Cost and Health Benefits from Integrating New Age Ayurveda into European Health Systems
Dr. med. Harsha Gramminger, Germany
General Health Costs are spiraling in all developed and developing nations of the world. In 2013, Germany spent almost €315 billion on health. This was an increase of about €12.1 billion compared to 2012: €3,910 in 2013 vs. €3,770 in 2012 per inhabitant. Type 2 Diabetes, Obesity, Hyperlipidemia, Hypertension & other “civilization” diseases are the main factors for these costs.
With over 8 million sufferers (in 2009 and growing), Diabetes Mellitus is one of the most widespread diseases in Germany. Serious “secondary complications” and “associated diseases” / co-morbidities include heart attack, stroke, athlete’s foot etc.
Total costs €3,817 includes three components: direct – disease, indirect, and associated complication.
Obesity is another new global epidemic and set to become the number one health problem globally by the year 2025. In 2013, 52% of all Germans were overweight, which is about 42.02 Million people! The associated conditions include: Type 2 Diabetes, Hypertension, Vascular diseases, Stroke, Coronary heart disease, Gall stones, Cancer, Sleep Apnea Syndrome, Diseases of the joints and of the skin, and more.
Clinical and practical experience is proven, that Ayurveda is able to improve the condition of both Type 2 diabetes and Obesity. Furthermore it is able by its lifestyle guidance and preventive holistic approach, to reduce and avoid follow–up diseases and costs.
The presentation will show with facts and figures how the wisdom of Ayurveda can be followed for the New Age to prevent, manage and cure such diseases. Figures for savings to the European Health care costs will be presented and discussed.